AAP
23
2
MRO
50
3
NTRS
49
2
ORLY
62
-2
KIM
51
-3
TJX
48
-6
PYPL
47
2
JPM
55
2
VLO
42
2
NOV
45
3
ORCL
73
-4
CHK
27
7
NAVI
57
2
GD
59
-4
BSX
69
-2
DVN
33
4
WU
14
2
SLG
62
-4
CPB
65
11
FOXA
41
4
AAP
23
2
MRO
50
3
NTRS
49
2
ORLY
62
-2
KIM
51
-3
TJX
48
-6
PYPL
47
2
JPM
55
2
VLO
42
2
NOV
45
3
ORCL
73
-4
CHK
27
7
NAVI
57
2
GD
59
-4
BSX
69
-2
DVN
33
4
WU
14
2
SLG
62
-4
CPB
65
11
FOXA
41
4
Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16

EW
Edwards Lifesciences

Last Price:
67.50
Seasonality Move:
2.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Edwards Lifesciences Price Quote

$67.50
+0.27 (+0.4%)
(Updated: September 18, 2024 at 6:55 PM ET)

Edwards Lifesciences Key Stats

Sell
16
Edwards Lifesciences (EW) is a Sell
Day range:
$66.69 - $71.70
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
29.23
P/S ratio:
6.79
P/B ratio:
5.45%
Volume:
11.3M
Avg. volume:
6.1M
1-year change:
-8.16%
Market cap:
$40.5B
Revenue:
$6B
EPS:
$2.43

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.22%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $866.1M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$591.4M
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $291M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 19.6%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 15.48%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 21.3%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

  • Who Are Edwards Lifesciences's Competitors?
    Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
    • Becton Dickinson & Co (BDX)
    • Boston Scientific Corp (BSX)
    • NeuroOne Medical Technologies Corp (NMTC)
    • Nutriband Inc (NTRB)
    • SINTX Technologies Inc (SINT)

Edwards Lifesciences Dividend Yield

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: 22% 0.88%
Revenue: 6.98% -1.26%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 16
Sell Recommendations: 0
Price Target: 79.42
Upside from Last Price: 18.13%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    713.5M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.8M EW shares are owned by insiders